[How long is the cupping time?]_ Effect_Efficacy

[How long is the cupping time?]_ Effect_Efficacy

I believe that many people know a little about cupping. Cupping is a treatment method of traditional Chinese medicine. It has special characteristics. Cupping can not only prevent diseases, but also treat diseases.Blood circulation, even if cupping has many benefits to the human body, but to properly cup, you must pay attention to time, how long is the cupping time appropriate?

Let ‘s take a look next.

One.

What to prepare before cupping. In addition to choosing the cupping equipment, you must also prepare hemostatic forceps, matches, cotton balls, liquid medicine, lubricants, 95% strength alcohol and other auxiliary supplies.

two.

How long is the cupping time? Generally speaking, the cupping time is between 10 minutes and 15 minutes, short for 5 minutes, and long for 30 minutes.

1. If the patient feels pain, is very tight, and is particularly uncomfortable, it is necessary to pull up the can early.

2. If the patient feels comfortable, the adjacent muscles are also fuller and stronger. In the case where the adsorption force of the jar is not very large, the cupping time can be longer.

3. If the person is weak and thin, the time is short, the strength is small, and the number of jars should be reduced accordingly.

4. If it is a person with a better physique and a stronger body, the suction time can be longer, the number of jars should be larger, and the absorption power needs to be increased.

5. For those who try cupping for the first time, the time is short.

If it is a person who often performs cupping treatment, the suction time should not be too short, and the suction power should be small.

6. For those who need excitement and improve their physical function, the suction time of the jar should be short, the strength of suction should be small, and the number of jars should be small.

7. If it is a flash tank, it is usually about 5 minutes to 10 minutes, which is mainly used to treat various paralysis diseases.

8. If it is a painful disease, the pain needs to be relieved, the suction time should be long, and the suction power should be large.

If it is an acute disease, cupping treatment should be performed once a day. For chronic diseases, cupping treatment should be performed every other day. Continuous treatment for 10 to 15 days is a course of treatment.

three.

What to do if blisters appear in cupping? Some cupping marks will appear after cupping, and some blisters will appear.

If blistering occurs, it may be related to cupping time or edema unless rheumatism.

The appearance of blisters is not a bad thing, and sometimes a foaming treatment method should be appropriately used in order to improve the effect of treatment.

If a blister occurs, you can disinfect it with iodine and alcohol, then pierce the edge of the blister with a disposable syringe, remove the water from it, and apply it with a potion or a scalding cream.

To avoid infection, you can take antibacterial drugs.

[How to eat rambutan]_ rambutan _ practice Daquan _ production method

銆愮孩姣涗腹鎬庝箞鍚冦€慱绾㈡瘺涓筥鍋氭硶澶у叏_鍒朵綔鏂规硶
Differentiate between the two groups: the silicon umbrella is divided into two groups: the main unit is the same as the main unit of the family.In the meantime, you can drill the chains and chains, and then pick up the chains, and then pick up the umbrellas, arbitrarily, the chains, the chains, the chains, and the chains.What’s the difference in the belly chain?1 銆 侀 椞 椋?The bag is very beautiful. The bag is full of diamonds, and the bag is stuck. The ammonia plating is not easy to drill, and the effect is very good. It’s very difficult to do it. It’s very difficult to do it.悆绾㈡瘺涓圭殑鏃跺€欙紝鍙鎷ㄥ紑鏌旇蒋鐨勬瘺鍒鸿交杞讳竴鎸わ紝鐧借壊閫忔槑鐨勬灉鑲夊氨闇插嚭鏉ヤ簡锛屼絾鏄悆绾㈡瘺涓硅鐢ㄧ墮鎱㈡參杞昏交鍦颁竴灞備竴灞傚挰锛屼笉鍙互蹇冩€ュぇ鍔涳紝鍚﹀垯寰堝鏄撳氨浼氭牳鏁h啘纰庯紝鑶滆倝鐩歌繛浜嗐€?2 銆 佽 尪 楗?鎶婄孩姣涗腹鏋滃3娲楀噣鍔犳按鐓庣叜褰撹尪楗紝鍙敼鍠勫彛鍥㈢値涓庤吂娉汇€傜孩姣涗腹妞嶆牚鐨勬爲鏍癸紝娲楀噣鍔犳按鐔叜褰撴棩甯搁ギ鏂欙紝鑳介檷鐏В鐑紱鍏舵爲鐨按鐓綋鑼堕ギ锛屽鑸屽ご鐐庣棁鍏锋湁鏄捐憲鐨勫姛鏁堛€?3銆佸埗铚滈ク銆佹灉閰便€佹灉鍐诲拰閰块厭銆?銆 人 姣 嬣 頗 髗 髗 咬 閒 閨 尨 氨 紨 紨 紨 細 紨 紨 細紗 将 嶔 板 圆 夋 燂 燴 畅 喬喬 尬 尌 氂 氬 氬 氕 氬 氕 氂 氬 氽 Ning 3You can’t read it, you can read it, you can’t do it, you can’t do it, you can’t do it, you can’t do it澶╁乏鍙炽€?The children’s abdomen is upset, the pets are arrested, and the people are arrested. They are in a state of affairs. They are plugged in. Hydrogen shocks are falling down. The key is not up to you. It’s up to you.硶鏄敤涓ゅ彧鎵嬩笂涓嬫彙浣忥紝鍍忓紑鐡剁洊涓€鏍峰皢瀹冩棆寮€銆?銆佺孩姣涗腹灞炴俯鎬ф按鏋滐紝澶氬悆瀹规槗鐢熺儹涓婄伀锛屾晠骞冲父鏈夊彛骞茶垖鐕ャ€佹墎妗冭吅鍙戠値銆佽劯闀块潚鏄ョ棙銆侀珮琛€鍘嬪帇銆佺墮鍛ㄧ梾銆佸彛鑷己鐑堛€佷究绉樸€佺棓鐤€佺儹鍜崇瓑鐑€х梾鑰呬笉瀹滃鍚冦€?銆佺孩姣涗腹鐨勬灉鏍镐笂鏈変竴灞傚潥纭笖鑴嗙殑淇濇姢鑶滐紝鍜屾灉鑲夌揣瀵嗙浉杩炪€傝繖灞傝啘浜虹殑鑲犺儍鏄棤娉曟秷鍖栫殑锛屽悆鍒拌倸瀛愰噷浼氬垝鐮磋偁鑳冨唴澹侊紝椋熺敤鏃朵竴瀹氳灏嗚繖灞傝啘鍓旈櫎骞插噣銆?

[Honey cures allergic rhinitis]_ bee sugar _ how to treat

銆愯渹铚滄不杩囨晱鎬ч蓟鐐庛€慱铚傜硸_鎬庝箞娌荤枟
榧荤値锛屾槸涓澶у嵈涓嶅奖鍝嶆甯告椿鍔紝璇村皬鏈夋椂鍊欏嵈闅惧彈寮傚父鐨勪竴绉嶇柧鐥呫€傚緢澶氫汉琚蓟鐐庡洶鎵帮紝姣忓ぉ璧峰簥鎴栬€呮湁鑺辩矇鐨勬椂鍊欓兘浼氭墦涓€杩炰覆鐨勫柗鍤忥紝杩樹細娑曟祦涓嶆锛岃€岃渹铚滃彲浠ユ不鐤楅蓟鐐庛€傛帉鎻¤渹铚滄纭殑椋熺敤鏂规硶锛屽苟涓旈暱鏈熷潥鎸佷笅鍘伙紝灏卞彲浠ョ湅鍒版晥鏋溿€傚钩鏃朵篃瑕佸娉ㄦ剰榧荤値鐨勯闃诧紝涓嬮潰鏉ヤ粙缁嶄竴涓嬪嚑绉嶈渹铚Destroy the sorrowful rule: 父 犺 渹 铚?50g, 绾㈣壊鐢滆彍 50g銆傜敤娉曪細 鐢滆彍娲楀噣銆佹崳纰庛€佹Θ姹侊紝鍔犱汉铚傝湝閰嶆垚 30% 鐨勬憾娑层€傛瘡涓蓟瀛旀瘡娆℃淮浜?5 婊淬€傛湰鏂归€傜敤浜庢參鎬ч蓟鐐庛€傚惈铚傝湝鐨勮€佸发鑴剧敤娉曪細 灏嗗惈铚傝湝鐨勮€佸发鑴惧垏鍓叉垚 9cm 鐨勫皬鍧楋紝姣忔鍜€鍤?1鍧楋紝鍜€鍤?5 闒 嗛 撓 咖 庡 鍑 鍑 鹑 湣 娓 o 纴 1 镞?2~3 娆°€傛湰鏂归€傜敤浜庢參鎬ч蓟鐐庣瓑銆傛偅鑰呭拃鍤煎惈铚傝湝鐨勫发鑴撅紝缁忓嚑鍒嗛挓鍚庯紝鎮h€呯殑榧诲鐜拌薄渚垮彲娑堝け銆傗憽铚傚发鑴?2 Lao Xuan Xuan Xuan Yao 1000g 鐢 ㄦ 硶 Ad?If you want to do it, you will be able to read it in Chinese, if you want to press it, if you want to click on it, you will be able to get it to 2 * ★ 庴 姣 忔  啦 啣 尗 尽 専 専 尽存蒙娣€ 12 灏忔椂鍚庯紝闄ゅ幓涓婂眰榛勮壊铚傝湣锛岀劧鍚庡皢鍓╀綑鐗╁啀鍔犳俯娴撶缉鎴愯啅锛屾瘡鏃ユ棭Sugan chain?1 娆 ★ 庴 姣 忔 Chain 帹 宸 券 啅 3 ~ 5g, 咖 屾 椂 浜 ﹀ 倲 嶈 涹 铚?5g銆傛湰鏂归€傜敤浜庡悇绉嶇被鍨嬮蓟鐐庛€傚鎱㈡€ч蓟鐐庢湁鏁堢巼涓?5% of Fen-ho у regulatory parameters altar Torreya meat  shackles on Election Chisuobaophas Juan?72% 銆 傗 醿 铚 傚 円 渆 渹 鑳 擞 厴 湴 測 渳 鑳 helm Press Jing Jing ruo 浫 浜 ﹀ 彲 鐢 ㄦ 硶 Ad?灏嗚渹鑳剁暐寰姞鐑紝鎻夋垚榛勮眴绮掑ぇ灏忋€傛棩鍤兼湇3 娆★紝姣忔 1 绮掞紝2 鍛ㄤ负 1 涓枟绋嬨€傜敤铚傝兌閰婃按婧舵恫娴稿強鎮e渚ч蓟瀛旓紝涔熷彲灏嗚渹鑳堕厞姘存憾娑茶鍏ュ柗闆惧櫒锛屽鍑嗛蓟瀛旂洿鎺ュ柗鍏ユ偅澶勶紝姣忔棩 2~3 娆★紝 7 鏃ヤ负 1 涓枟绋嬨€傛湰鏂归€傜敤浜庢€ユ參鎬ч蓟鐐庛€傗懀绾渹鑳?25g 钁佃姳绫芥补鑻ュ共锛屽ザ娌归€傞噺銆傜敤娉曪細 鍏堝皢绾渹鑳舵竻娲楀共鍑€锛岀矇纰庯紝鐒跺悗鏀惧叆鐡蜂钩浣撳唴锛屽姞灏戦噺濂舵补鍏呭垎纾ㄧ锛屽啀鍔犱汉钁佃姳绫芥补鑷?125g 呼 呮 妈 狄 峰 曎 囧 囧 寢 廀 圀 浜 庡 建 绠?鍐呬繚瀛樺鐢ㄣ€傛不鐤楁椂鎮h€呭彇渚у崸锛屽ご閮ㄥ瀭涓嬶紝鐢ㄨ渹鑳舵补瑁旂偣娑傞蓟瀛旓紝骞剁敤妫What are you looking for? Do you know what you are doing? 鏃ユ秱 2娆°€傛湰鏂归€傜敤浜庢櫘閫氬瀷鎬ユ€ч蓟鐐庛€傝繃鏁忔€ч蓟鐐庨闃?锛氭敞鎰忎繚鏆栥€傜壒鍒槸绉嬪啲瀛h妭锛岀櫧澶╃┛鍘氱偣鐨勫濂楁垨缇界粧鏈嶏紝鏅氫笂鐫¤鏈€濂界┛涓婄琛g瑁ょ潯瑙夈€?锛氭嫆缁濆喎楗€傚钩鏃舵渶濂戒笉瑕佸悆闆硶銆佸喎楗瓑杈冨噳鐨勪笢瑗裤€?锛氱敓娲昏寰嬨€傛瘡澶╄嚦灏戜繚璇?灏忔椂鐨勭潯鐪狅紝涓斿仛鍒版棭鐫℃棭璧枫€?锛氬澶氳繍鍔ㄣ€傚钩鏃跺彲浠ュ鍋氫簺濡傝窇璺戞銆佹父娓告吵绛夋湁姘ц繍鍔紝鎻愰珮韬綋鏈鸿兘銆?锛氶€傚綋鑽墿娌荤枟銆傚鏋滈蓟鐐庤緝閲嶏紝鍙€傚綋鍚冪偣娌荤枟榧诲銆佺紦瑙eご鐤笺€佹姉杩囨晱鐨勮嵂鐗┿€?锛氳繙绂荤┖璋冦€傞蓟鐐庢偅鑰呭崈涓囦笉瑕佸湪绌鸿皟搴曚笅鍚癸紝瓒婂惞瓒婁弗閲嶏紝涓€瀹氳杩滅绌鸿皟椋庡悜锛岄伩鍏嶇洿鍚广€?锛氶┍瀵掋€傚钩鏃跺彲浠ラ€氳繃鍠濈偣濮滄堡鏉ラ┍椹变綋鍐呯殑瀵掓皵锛屾墦鍠峰殢涔熸槸韬綋鎺掑瘨姘旂殑涓€绉嶆柟娉曞摝銆?

[How to cook fried fat sausages?】 _How to do_Homely practice

銆愮垎鐐掕偉鑲犳€庝箞鍋氬ソ鍚冿紵銆慱濡備綍鍋歘瀹跺父鍋氭硶
This is a link between a chain and a chain, a chain of links, a chain of keys, a chain of keys, a chain of keys, a chain of keys, a chain of keys, a chain of keys, and a chain of picks.涓€浜涗笅閰掕彍銆傛渶甯歌鐨勯櫎浜嗕竴浜涘皬鍜歌彍涔嬪锛岃繕鍖呮嫭鑺辩敓绫崇瓑绛夛紝鍚屾椂涔熷寘鎷竴浜涜偉鑲犵被鐨勯鐗╋紝鍠濋厭鐨勬湅鍙嬩篃鏄潪甯稿枩娆㈠悆鐨勩€傚湪鐢熸椿涓偉鑲犵殑鍋氭硶鏄潪甯稿鐨勶紝閭d箞鐖嗙倰鑲ヨ偁鍒板簳鎬庝箞鍋氭墠鏈€濂藉悆鍛? 绗竴锛岃偉鑲犻渶瑕佺壒鍒殑澶勭悊鑲ヨ偁涔嬫墍浠ュ悆鐫€鑴嗭紝閭f槸鍥犱负澶勭悊鐨勬柟娉曞緱褰撱€The Chinese version of the Chinese version of the Chinese version of the Chinese version of the monastery ╂press the uncle 咶 咲 奲 奀 嚑 娆 ‘璣 钖 庯 纴 鎶 婅 側 尃 ヨ エ ヨ ヨ ヨ ヨ浜涚洂宸达紝鐒跺悗鍍忔礂琛f湇閭f牱锛岀敤鐩愬反鍘绘弶鎼撹偉鑲犮€?What are you talking about? How are you going? How are you going to do it? You’re going to be together. You’ll be able to see what’s going on here. What’s going on? What’s going on?鎶婅偉鑲犳礂濂戒箣鍚庯紝鍒囨垚澶у皬閫備腑鐨勬锛屽姞鍏ュぇ钂溿€佺敓濮溿€佹枡閰掕厡鍒跺崐灏忔椂宸﹀彸锛岄€氳繃鐢ㄥぇ鏂欒厡鍒讹紝鍙互鍘婚櫎鑲犲瓙鏈韩鐨勮嚟鍛炽€?绗簩锛岄厤鍚堢孩杈f鐖嗙倰锛屽懗閬撴洿棣欑敤杈f鐐掑嚭鏉ョ殑鑿滄槸寰堝鏄撳嚭鍛抽亾鐨勶紝鎵€浠ユ妸鑲ヨ偁鑵屽埗濂戒箣鍚庯紝鍔犲叆灏戣鐨勬穩绮夋按銆?娣€绮夋按鑳借鑲ヨ偁鐨勫彛鎰熸洿鑴?This is a good example of how to do it, and how to do it, and how to do it, how to do it, how to do it, how to do it, how to do it, how to do it, how to do it, how to do it, how to do it, how to do it, how to do it懗閬撻兘娌℃湁锛屽弽鑰屾洿棣欙紝杈e姴鍎垮崄瓒崇殑鑲ヨ偁锛岄厤鐫€閰掓潵鍚冿紝鍙f劅浼氳偉鑲犲姴鐖嗭紝闄や簡娣€绮夋按锛屽悓鏃跺湪鐐掔殑鏃跺€欓渶瑕佸紑澶х伀鏉ョ垎鐐掞紝杩欐牱鍚冭捣鏉ュ彛鎰熸墠鑴嗐€傜涓夛紝閰嶇偣鍏朵粬閰嶈彍鑲ヨ偁涓嶄細娌硅吇寰堝鏈嬪弸鍦ㄧ倰鑿滅殑鏃跺€欙紝浼氫範鎯€х殑鍦ㄩ攨鍐呭鍔犳补锛岃€岃繖閬撶垎鐐掕偉鑲狅紝涔熻娌瑰鎵嶉锛屼絾鏄繖鏍风殑鑲ヨ偁澶氬悆鍑犲彛浼氬彂鐜帮紝鏈夌偣鑵诲彛銆傛墍浠ラ厤鐐瑰惛娌规€ф瘮杈冨ソ鐨勮彍锛屽仛鍑烘潵鐨勮偉鑲犲ソ鐪嬪張濂藉悆锛屽湪鍋氳繖涓垎鐐掕偉鑲犵殑鏃跺€欙紝鍙互鍔犱竴浜涢厤鑿滐紝璇稿鍦熻眴鐗囦箣绫荤殑锛屽湡璞嗙墖閲岄潰鍚告敹浜嗚荆妞掓补涔嬪悗锛屼細鍙樺緱闈炲父骞茬埥锛屽悆璧锋潵鏈夊共閿呭湡璞嗙墖鐨勬劅瑙夛紝鍙槸鍦熻眴鐗囪鍒囪杽涓€鐐广€?Quilt, squirrel, chrysanthemum, silicon, fine detail, capture, capture, sorrow, sorrow, sorrow, sorrow, sorrow, sorrow鍙兘浼彂鐜帮紝鍠濅簡閰掍箣鍚庯紝鍐嶆潵鍚冮キ灏辨劅瑙夌背楗病鍛抽亾浜嗭紝鎵€浠ュ湪鑲ヨ偁閲岄潰閰嶇偣璞嗚眽锛岃繖閬撹彍灏变細姣旇緝涓嬮キ銆?

[How long can steamed pumpkins be cooked? How long can pumpkins be cooked]_Pumpkins_How long to steam_Practice

銆愯捀鍗楃摐澶氶暱鏃堕棿鑳界啛_鍗楃摐涓€鑸捀澶氫箙鑳界啛銆慱鍗楃摐_钂稿涔卂鍋氭硶
鍗楃摐鐨勮惀鍏讳环鍊间竴鐩存槸姣旇緝楂樼殑锛屾垜浠湪鍚冨崡鐡滅殑鏃跺€欙紝澶у鏁伴兘浼氶€夋嫨灏How to do it? Broadcasting and broadcasting: The key is the key, the key is the key, the key is the key, the key is different, the key is different, and the key is different.The elder brother is the best one, the younger one is the best one, the younger one is better, the other one is better, the better one is, the better one is, the better one is, the better one is, the better one is, the better one is, the other one is broken.Jingyue Cliffs, Ning Ge, Ning Ge, Pan Ding, Pan Ding, Ding Ding, Ding Ding, Ding Ding, Ding Ding, Ding Ding, Deng Ding, Backpack, Ding, Ding, Ding, Ding, Backpack, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, Ding, D, D, D, D, D, D, D, D, D, D, D, D, D, D, D, D, D, D, D, D, D, D D钂稿崡鐡滄槸涓€閬撹惀鍏讳环鍊奸珮锛屽懗閬撻鐢滅殑鑿滆偞锛屾墍鐢ㄧ殑鏄櫘閫氱殑澶т紬椋熸潗鈥斺€This article is written by the Chinese government and the Chinese government. It ‘s very simple. It ‘s very simple. It ‘s a new village. It ‘s a new village, and it ‘s very interesting.崡鐡滃お纭紝闇€瑕佷竴瀹氱殑鏃堕棿鎵嶈兘灏嗗叾钂哥啛锛岄偅涔堣捀鍗楃摐涓€鑸捀澶氫箙鍛?鐢变簬鍗楃摐澶栫毊澶‖锛屽洜姝ゅ湪钂稿崡鐡滅殑鏃跺€欐墍闇€瑕佺殑鏃堕棿瑕佺◢寰暱鐐癸紝涓€鑸?5 闒 旓 宸 幸 劸 銆  鏋 揆 捄 撄 椬 旕 氕 旉 椉 楉 光 慉 光 楉╅ 敦 湦 Fallen back to the nickname 姽 員 鐡 撆 咄 撮 惏 撏 撲 擲 溶 纏 鍏 卒 囒 雒 囒 囒 剒 尜 尜 尧尧 尧尧 尧尧 專 尜 尧尧 尧尧 專 尜 尧 專 尜 就 尧 璜殑镞堕落棿棿鎻″緱鎭板埌濂藉銆傝€屽埗浣滃叾浠栬彍璋辩殑璇濆垯鏄渶瑕佹妸澶栫毊鍓婃帀锛屽啀杩涜钂哥叜锛屼竴鑸?0 ‘?0鍒嗛挓鏃堕棿鍗冲彲銆傝捀鍗楃摐闇€瑕佸闀挎椂闂达細鐐掕彍閿?0 旛 掓 椋 椋 椂 掎 揎 漋 浠 惱 氱 敱 敱 敕 掕 啍 咄 撨 瀛 愯 捯 捀 捕 插 囒 囒 盒 囒 盔 囒 盔 盔 盔 盔 盔 盔 盔 盔 盔 盔 盔 盔 盒 盒 盒 盔 盔 盔 盔 盒 盒 盒 盒 盒 盒 盒 盒 盒 盒 牒 牒 囒 牒 剒 牒忔湁鍏筹紝涓€鑸负浜嗙啛鐨勫揩鐐瑰彲浠ユ妸鍧楀垏鐨勫皬涓€鐐癸紝(涓€鑸澶寸殑涓€鍗婂ぇ灏?寮€濮嬪彲浠ョ敤澶х伀锛屽紑閿呬互鍚庢敼鐢ㄥ皬鐏紝20鍒嗛挓灏辫冻澶熶簡銆備篃鍙互鍦?5鍒嗛挓鏃跺€欙紝鎵撳紑鐩栧瓙锛岀敤绛峰瓙鎵庝竴鎵庯紝鑳藉杞绘澗鐨勬墡閫忥紝璇存槑宸茬粡鐔熼€忎簡I ‘m sorry, I ‘m sorry, I ‘m sorry, I do n’t know what to do, I do n’t know what ‘s going on, what ‘s going on, what ‘s going on, what ‘s going on, what ‘s going on, what ‘s going on?竴浼氬効銆傝捀鍗楃摐闇€瑕佸闀挎椂闂达細寰尝鐐?0鍒嗛挓涓€鑸潵璇达紝寰尝鐐夎捀鍗楃摐鐨勬椂闂村ぇ姒傚湪10鍒嗛挓宸﹀彸灏卞浜嗭紝娉ㄦ剰鏄珮鐏?0 闒 旛 銆 Effects the inertial umbrella, the surplus, the green, the new, the new, the general, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, the, and, the, the,跺彲浠ユ牴鎹嚜瀹跺井娉㈢倝鐨勫姛鐜囨潵璋冩暣鏃堕棿銆傚崡鐡滄湁涓€瀹氱殑纭害锛屽ぇ瀹朵笉鐢ㄦ媴蹇冭捀杩囧ご锛屽叾瀹炶蒋鐑備竴鐐瑰彛鎰熸洿濂姐€傚鏋滃ぇ瀹惰捀浜?0鍒嗛挓杩樿寰楀崡鐡滀笉澶熻蒋绯紝鍙互鍐嶉珮鐏捀5鍒嗛挓銆傝捀鍗楃摐闇€瑕佸闀挎椂闂达細楂樺帇閿?嗒 嗛 挓 淓 樓 呇 呰 區 捗 楃 擐 婃 婃 Benzene 5 銆?鍒嗛挓灏辩啛浜嗐€傞珮鍘嬮攨閲岄潰鐨勫帇鍔涙瘮钂搁攨澶у緢澶氾紝鐓垨钂镐笢瑗挎椂灏辩渷浜嗗緢澶氭椂闂淬€傝鏄嬁楂樺帇閿呰捀鍗楃摐瓒呰繃10鍒嗛挓锛岄偅鍗楃摐灏辩叜鐨勫お鐑備簡锛屽彛鎰熶篃浼氭湁褰卞搷鐨勩€?

Datong Coal Industry Co., Ltd. (601001): Capacity adjustment, landing and extension growth accelerated

Datong Coal Industry Co., Ltd. (601001): Capacity adjustment, landing and extension growth accelerated

Backed by Tongmei Group, enjoying the Daqin Railway Transportation Dividend Company is the largest coal listed company in Shanxi.

At the end of 2018, the company’s approved coal production was 3060 years / year. The production mines in the province are close to Datong City, the starting 杭州桑拿 point of the Daqin Railway shipment, and have direct access to Qinhuangdao Port.

For several other thermal coal production enterprises, transportation costs and outbound transportation capacity are the company’s core competitive advantages.

  Significant benefits were obtained from the adjustment of the mining area. In 2013-2017, the core assets of Tashan Mining Company adjusted the structure of the coal production area, replacing high-cost, low-efficiency mines, and improving the allocation ratio of high-quality mines.

Tashan Mine has now become the company’s main source of profit, and supporting pit mouth factories has effectively saved coal transportation costs.

The mine has completed the nuclear capacity increase in August 2019, and the approved capacity has been increased from 1500 mm / year to 2500 mm / year after completion.

After the increase of Tashan Minerals carbon nuclear production, the profit level will further increase, and with the advantages of railway transportation capacity, it will have the ability to overcome risks.

  The group’s debt ratio is relatively high. Increasing the asset securitization rate is one of the ways to reduce leverage. The coal production capacity of Tongmei Group is about 1.

600 million tons, five times the number of listed companies.

In accordance with its commitment to avoid peer competition, Tongmei Group will choose opportunities to inject high-quality assets for coal production and operation.

In order to speed up the asset injection speed of the listed company, the group has 8 approved production capacities including its coal mines, Silaogou, Jinhua Palace, Majiliang, Yungang, Yanzishan, Sitai, and Xuangang Coal and Power.The mine with the expected mining life is delivered to the company for hosting.

2020 is the year when Shanxi Province reforms and closes the customs. The current group size has a high asset-liability ratio problem. Increasing the asset securitization rate can effectively reduce corporate financial leverage.

The Group’s mine production nuclear value added, cost control strengthening and connection changes are expected to become asset injection catalysts.

  Earnings forecast and investment grade: We expect net profit for 2019-2021 to be 7, respectively.

0/6.

5/6.

30,000 yuan, the corresponding EPS is 0.

42/0.

39/0.

38 yuan, the current sustainable corresponding PE is 10/11/11 times.

Combining the absolute and relative estimation methods, we believe that the company’s reasonable estimation is 4.

62 yuan.

Covered for the first time, giving “overweight” rating.

  Risk reminder: Xinzhou Kiln’s profitability continues to grow; it is difficult to predict the cost of excavation, and the possibility of increase is not ruled out; the progress of asset injection may be less than expected

Supor (002032) 2019 Semi-annual Report Express Report Comments: Performance in line with expectations Expected cost control effect is obvious

Supor (002032) 2019 Semi-annual Report Express Report Comments: Performance in line with expectations Expected cost control effect is obvious
Matters: The company released the 2019 semi-annual results report, and the company’s total operating income in 2019H1 was 98.3.6 billion, an increase of 10 years.15%; total profit 10.97 ppm, an increase of 16 in ten years.58%; net profit attributable to parent company8.38 ppm, an increase of 13 in ten years.35%. Comment: Performance is in line with expectations.In 2019H1, the company achieved revenue of 98.3.6 billion, an increase of 10 years.15%, the second quarter achieved revenue of 43.62 ppm, an increase of 10 in ten years.09%, Q2 achieved net profit attributable to mother 3.23 ppm, an increase of 12 in ten years.62%, in line with our Air Force performance forecast: revenue and profit growth in the 10-15% range.Domestic market: According to data from Aowei Cloud, the overall size of the small appliance industry in H1 2019 is 288.8 ppm, a ten-year increase2.At 7%, the company benefited from the increasing product line and the expansion of the brand’s competitive advantage, the market share increased, and the industry’s concentration increased further.In terms of online channels, Taobao data shows that Supor’s online retail growth in 19Q2 increased by 24%, which is higher than the industry average, but the growth rate was slightly lower than Q1 (31%). Export market: Relying on SEB’s comprehensive global layout, the company is expected to continue to benefit from the transfer of orders from SEB, and the export business income will continue to grow steadily. The company expects the scale of related party transactions to reach 52 in 2019.30,000 yuan (the actual amount in 2018 was 46.300 million, + 13%). During the period, the cost control effect was obvious and the profitability was stable.19H1 operating profit 11.12 ppm, an increase of 18 in ten years.86%, achieved operating profit in the second quarter4.33 ppm, an increase of 30 in ten years.13%; 19H1 total profit 10.97 ppm, an increase of 16 in 杭州桑拿网 ten years.58%, profit growth in the second quarter4.180,000 yuan, an increase of 23 in ten years.49%, profit growth is higher than revenue, mainly due to the company’s cost control effect is obvious, the sales expense ratio during the H1 period, the management expense ratio fell to 0.57pct and 0.23pct, achieving a rapid growth in the return on investment of the company’s funds;38 ppm, an increase of 13 in ten years.35%, Q2 achieved net profit attributable to mother 3.23 ppm, an increase of 12 in ten years.62%, the growth rate is lower than the largest profit is mainly due to the increase in subsidiaries’ income and expenses. Multi-brand and multi-category layout is formed, and long-term stable development is expected.With years of R & D technology accumulation and technical support provided by the SEB Group, the company has industry-leading product innovation capabilities.In addition to continuing to maintain a leading position in the cookware and small kitchen appliances industries, the company is currently developing well in new categories such as kitchen appliances and environmental appliances, and the multi-category product matrix continues to contribute to the company’s growth.In terms of brand matrix, the company has successively dated growth engines.With the further deepening of the synergy with SEB Group in the future, the company’s long-term steady development is expected. Investment suggestion: We maintain the company’s EPS forecast for 19/20/21 to be 2 respectively.43/2.87/3.30 yuan, corresponding PE is 28/24/21 times.As the leader of the domestic cookware industry, Supor has been cultivating cookware for more than 20 years. The new layout of high-end cookware has broad development space.At the same time, the company’s strength in research and development and the channel’s competitive advantages, entered the field of household electrical appliances and other fields, the expansion of categories has become an important growth point of Supor’s medium and long-term development.Maintain the “strong push” level, maintain the target price of 73 yuan, corresponding to 30 times PE in 19 years. Risk warning: industry competition intensifies; raw material prices rise.

Dongcheng Pharmaceutical (002675): Interim report results in line with expectations The nuclear medicine sector continues to grow rapidly

Dongcheng Pharmaceutical (002675): Interim report results in line with expectations The nuclear medicine sector continues to grow rapidly

Event: The company released its semi-annual report for 2019 and achieved operating income13.

2.7 billion (+39.

60%), net profit attributable to mother 1.

7.8 billion (+59.

14%), after deducting the non-deductible net profit of return to mother 1.

8.8 billion (+58.

46%).

After excluding the consolidation factor of Antico, the company’s net profit growth rate in the first half of the year was approximately 45%.

The Air Force Company announced that its profit increased from 50% to 65% from January to June of 19, and its actual performance was in line with expectations.

Nuclear medicines continued to grow at a high speed, and the nationwide distribution of nuclear pharmacies continued to advance the revenue of nuclear medicines in the first half of the year to 51,290.

370,000 yuan (+32.

14%), maintained a rapid growth momentum, and overall profits increased by about 30% (excluding factors such as supplementary nuclear pharmacy depreciation).

Among them, Yunke Pharmaceutical achieved operating income of 22,384.

690,000 yuan (+20.

03%) and a net profit of 10288.

300,000 yuan (+23.

70%), net profit attributable to mother is 53.61 million yuan.

Based on the clinical application of complications, Yunke injection is being developed in the evidence-based medicine research of the pain department. The development of indications / departments is expected to further open up the space for growth.

Shanghai Xinke achieved operating income of 12,647.

820,000 yuan (+11.

2%) and net profit of 2546.

210,000 yuan (+ 15%), net profit attributable to mother 13.33 million yuan.

Antico achieved operating income of 16,664.

07 (+ 40%), of which 18F-FDG revenue is about 1.

400 million (approximately + 30%) and a net profit of 6012.

RMB 870,000 (+20.

78%), the net profit growth rate is 天津夜网 slower than the income growth rate is mainly due to: 1) the first half of this year confirmed that equipment sales revenue is higher than the same period last year, this business profit margin is lower than 18F-FDG; 2) add nuclear pharmacy depreciation and other expensesIncrease, but the increase in the number of nuclear pharmacies is conducive to the company’s long-term performance growth.

In the first half of the year, the national layout of the company’s nuclear pharmacy progressed steadily. Andyco added two nuclear medicine centers in Liaocheng and Liuzhou, and now has 11 GMP certificates. Completed the acquisition and holding of four companies: Guangdong Roundabout, Hunan Roundabout, Kunming Roundabout, and Sichuan Roundabout.A 45% interest will be quickly added to each of the four nuclear medicine centers in Guangdong, 杭州桑拿网 Hunan, Yunnan and Sichuan.

Antico’s existing and under construction nuclear pharmacies cover provinces and cities with rapid increase in installed PET-CT capacity and large equipment holdings. In the future, it will continue to benefit from the increase in inspections in the corresponding regions to ensure rapid growth in performance.

The volume of common preparations continued to increase rapidly, and the prices and prices of heparin raw materials rose in the first half of the year.

710,000 yuan (+78.

7%), of which nadroparin calcium income is about 200 million (about + 100%), and continues to maintain a rapid volume trend.

The API has realized operating income of 52916.

380,000 yuan (+28.

05%), achieving a gross profit of 14,329.

72 million (+ 61%), mainly due to the elimination of pig production capacity in the first half of the year due to swine fever epidemic, the price of crude heparin continued to rise, and it was converted into downstream APIs. As a result, the company also increased its market development efforts and the amount of APIs for heparinPrices go up.

Zhongtai Biological achieved operating income of 52.43 million yuan (+ 8%) and profit of 6.22 million yuan (-31%). However, the current price of titanium sulfate is at the bottom, and the sales expense ratio continues to increase slightly. Operating cash flow is slightly increased.Outstanding improvement in the first half of the company’s sales expenses 26.

40%, an increase of 4 over the same period last year.The 22 singles are mainly due to the change in the company’s revenue structure and the increase in the proportion of nuclear medicine / general preparations revenue.

Net operating cash flow for the first half of the year was 258.97 million yuan (+47.

77%), exceeding the current net profit. The net operating cash flow in 19Q2 was 219.23 million yuan, and in 19Q1 it was only 39.74 million yuan.

Earnings forecast and investment rating We believe that the nuclear medicine industry has high barriers, a large market space and good growth.

In the short term, PETCT configuration approval authority is decentralized, SPECT configuration does not need to be approved, and the policy is favorable for the rapid installation of related equipment. 锝[99mTc]labeled drugs and 18F-FDG are expected to usher in a period of rapid growth.Announcement of the annual configuration plan for large-scale medical equipment. It is proposed that by 2020, the PETCT is planned to be deployed within 710 units, with an increase of 377 units. It is expected that by the end of 19, the installed capacity of PETCT will reach 500 units.

In the long run, overseas heavy-duty therapeutic nuclear medicines will be listed in the country one after another. The existing domestic nuclear medicine production and sales network must be re-established to accelerate the expansion of the nuclear medicine market. Domestic nuclear medicine companies are expected to continue to benefit.

We estimate that the net profit attributable to the mother of the company on 19/20/21 will be 4.

10 billion, 5.

0.6 billion and 6.

23 trillion, the growth rate is 43% / 26% / 23%, the corresponding EPS is 0.

50 yuan, 0.

63 yuan, 0.

78 yuan, PE is 23X, 19X and 15X.

Company evaluation: 1) Nuclear medicine: Net profit attributable to mother in 19 years 2.

Considering the oligopoly competition in the nuclear medicine sector, which is USD 8.1 billion, an increase of 33%, the barriers are very high, the competition is good, the market space is large, and the profitability is very strong. A certain premium should be given, and 40 times PE, which is estimated to be 112 billion yuan.
2) Ordinary preparations: Low-molecular-weight heparin preparations represented by nadroparin calcium have maintained rapid growth, with a net profit of 19 years.

61 ppm, giving 25 times PE, an estimated 1.5 billion.

3) The 19-year net profit of the bulk drug business reduced group expenses, etc. 0.

58 trillion, giving 10 times PE, for a market value of 6 trillion in 2019.

The company has a reasonable market value of 13.3 billion in 19 years and maintains a “buy” rating.

Risk reminder: APIs, non-recurring gains and losses, changes in exchange gains and losses affect the overall net profit; the growth rate of nuclear drugs is less than expected.

Xinhecheng (002001) 2019 Interim Review: The recent rise in vitamin prices is optimistic about the company’s future development

Xinhecheng (002001) 2019 Interim Review: The recent rise in vitamin prices is optimistic about the company’s future development

Event: On August 23, 2019, the company announced the 2019 interim report performance: 38 revenue.

6.7 billion, an annual decrease of 16.

85%; net profit attributable to mother 11.

56 ‰, a decrease of 43 per year.

87%; Estimated increase in average net asset income by 7.

00%, down by 6 every year.

87 units.

Comments: 1. The performance of the interim report company in 2019 decreased by 43 compared with the previous year.

87%, mainly due to the high price of vitamins in 2018H1; the second phase of the employee shareholding plan has been 武汉夜生活网 completed, and the company is committed to promoting development.

The 2019 Interim Report revealed that the company realized net profit attributable to mothers11.

56 ‰, a decrease of 43 per year.

87%.

The company achieved revenue of 38 in the first half of 2019.

67 ppm, a reduction of 16 per year.

85%; the company’s performance in the first half of 2019 has improved, first of all, the company’s flavor and fragrance conversion products and nutrition prices have fallen to varying degrees, and the flavor and fragrance business revenue has decreased by 16%.

83%, the income of nutrition business decreases by 21 every year.

52%.

The average price of the VA market in 2019 was 370.

70 yuan / kg, down 64 a year.

71%, down 2 from the previous month.

25%; 2019H1 VE market average price is 43.

85 yuan / ton, down 46 per year.

12%, up 14 from the previous month.

52%; As of May 8, 2019, the second phase of the company’s employee shareholding plan has been completed, and a total of 1,185 shares of the company’s shares were purchased through auctions on the secondary market.

510,000 shares, accounting for 0 of the company’s total share capital.

55%, the transaction amount is 2.

20,000 yuan, the average transaction price is about 16.
.

98 yuan / share.

2. Vitamin demand continued to grow steadily, and the company further consolidated the VA capacity 1 additive currently owned by leading companies and replaced VE oil capacity 2.

It is expected that the company will release two kinds of vitamin E acetate oil production capacity in the fourth quarter of 2019. At present, the completion of the project has reached 85%, and the company’s VE oil production capacity will reach 4 replacements.

Vitamins have complex technology and large barriers to entry, so the market is highly concentrated. The company is a leading company in the global vitamin industry.

The domestic feed industry is developing steadily, with a better economy, and vitamin demand will continue to grow steadily.

3. The methionine project is advancing steadily. It will become a leading company in the domestic methionine industry in 2021. The company currently has a methionine production capacity of 5, and has 25 tons of capacity under construction.

At present, domestic methionine is heavily dependent on imports. In the next three years, the throughput of domestic manufacturers will gradually be further released and technological development. The production of insulin methionine is fully capable of self-sufficiency, while there is still room for export. In the future, more import dependence will intensify domestic supply.trend.

4. Intensified Sino-U.S. Trade friction brings new development trends to Xinhecheng. The US President replaced on August 1, 2019 on social media, saying that China will impose a 10% tariff on the remaining 300 billion yuan worth of goods in China.

But for the vitamin industry, it will be less affected because China imports very few products from the United States, and only some amino acid (cholesterol methionine derivatives, etc.) products are imported from the United States.Hecheng will usher in new growth potential.

In terms of exports, 75% of the world’s vitamins are produced in China, and the United States depends on imports of trace vitamin products from China. Even if the trade war intensifies, the vitamin supply and demand balance in the world market will not be broken.
5. New material business has huge potential for future development. As a new growth point for the company, the new material business is trying to create a new and successful company.
In the first half of 2019, the revenue of new materials business exceeded 116.

78%.

At present, the company has been completed1.

5 PPS (polyphenylene sulfide) production lines and 1,000 tons of PPA (high temperature nylon) production lines.

The growing demand for the new material industry continues to expand. In the future, the company will accelerate the construction of an industrial chain in which polymer materials are polymerized, modified, and processed. This will increase market share and expand the company’s profitability.

6. The Heilongjiang bio-fermentation project steadily advanced in March 2018. The company announced that its wholly-owned subsidiary Biotechnology will use self-raised funds to invest in the construction of a bio-fermentation project in Suihua, Heilongjiang, with a total investment of US $ 3.6 billion.

The estimated investment recovery period of the project is 7.

In 8 years, the total supplementary capacity after completion was 39.

23 months.

The bio-fermentation project will form an integrated industrial chain of starch milk-glucose- lutein-hexanoic acid-sorbitol. At the same time, the downstream of sorbitol can be extended to VC to further improve the product structure.

In April 2019, the company participated in the auction of the right to use 395,730 square meters of industrial land in Heilongjiang Suihua Economic and Technological Development Zone and won the bid on the basis of 97541 square meters of industrial land acquired last September. This time, it participated in the auction of land use rights and further improvedThe company’s comprehensive competitive advantages ensure the smooth implementation of the company’s development strategy.

It is expected that after the project is completed, the company’s long-term profitability will be further enhanced.

7. Investment rating and estimation: It is estimated that the net profit attributable to the mother in 2019/20/21 will be 27.

54/31.

15/35.

8.5 billion, PE is 16.

69/14.

75/12.

82 times, give “recommended” rating.

8. Risk warning: market competition 北京夜网 is intensifying, exchange rate changes, raw material price fluctuations, and environmental protection policies are becoming more severe.

Yuyue Medical (002223) Quarterly Report Comment: Oxygen Concentrator Clears Inventory Performance and Low Expectations

Yuyue Medical (002223) Quarterly Report Comment: Oxygen Concentrator Clears Inventory Performance and Low Expectations
The performance of the third quarter report for 2019 is slightly lower. It is expected that the company will release the third quarter report for 2019 on October 23, achieving operating income / net profit attributable to mothers / net profit attributable to non-mothers.56/7.13/6.850,000 yuan, an annual increase of 11.82% / 13.51% / 14.67%, the third quarter of 19 operating income / net profit attributable to mothers / net profit after deducting non-mother growth rates were 10.18% / 13.55% / 15.40%, slightly lower than market expectations.We adjust our profit forecast and expect the company’s EPS for 2019-2021 to be zero.84/0.98/1.14 yuan, adjust the target price to 24.58-26.55 yuan, maintain “Buy” rating.  The high expenses in the first three quarters of 2019 affected the profit. The Tmall flagship store was closed by self-employed and heavy commercial products. The company’s gross profit margin in the first three quarters of 2019 was 41.92%, an increase of 1 per year.75 points.The company’s sales expenses and management expense ratios for the first three quarters of 2019 were 10 respectively.67% and 5.30%, ten years +0.82 points and -0.30pct.The company continues to invest heavily in research and development, with research and development expenses reaching 1 in the first three quarters of 2019.09 million yuan, an increase of 65 in ten years.5%, accounting for 3.08%, increase by 1 every year.00pct.Changes in exchange rates have led to a decrease in foreign exchange earnings. The company’s financial expenses for the first three quarters of 2019 were -17.52 million yuan, reducing annual foreign exchange earnings by approximately 16 million.The increase in expenses has dragged down the company’s overall performance.  Home medical care: The inventory of important single-product oxygen generators weighed down the overall performance. We estimate that the company’s blood glucose test strips / electronic sphygmomanometers / ventilator revenue growth rates in the first three quarters of 2019 exceeded 40% / 30% / 20%, respectively, and the growth is better.However, in order to clear up the problems left by history, the company proactively reduced the inventory and sales possibility of important single-product oxygen generator offline distributors. We estimate that the revenue decline in the first three quarters of 2019 will fall by 0-10%, and gradually reach the first three quarters of 2019.Offline sales declined slightly in the first half of the year.In the first three quarters of 2019, we will increase sales of home medical devices online by about 25%, with a steady growth rate.We believe that the inventory clearance of oxygen generators in 4Q19 will affect the basic digestion, and the income growth of the home medical business will accelerate.We expect the company’s home medical business online sales to increase by about 25% in 2019, and offline will be basically the same as last year.  Medical clinical: The upper limbs resumed growth, and Zhongyou continued to increase its volume. After completing the technical reformation of the upper limbs, after the first three quarters of 2019, the growth rate of income and non-net profit was about 20%.In addition to its own disinfection and control products in hospitals, Zhongyou Likang also develops consumer products for consumer use. The product line is further enriched and gross profit margins have increased. We estimate that Zhongyou ‘s revenue growth 无锡桑拿网 in the first three quarters of 2019 will exceed 20%, and net profit growth will exceed 50%.We expect the company’s medical clinical business revenue to increase by 20-25% in 2019.  Waiting for the second half of the year to accelerate its performance and maintain the “Buy” rating. Considering the pressure on the sales of oxygen generators and other products, we adjusted the corresponding product revenue, sales expense ratio and management expense ratio.46/9.86/11.4.6 billion (previous average 8.58/10.00/11.(61 ppm), with an increase of 16% / 17% / 16% in the past. The current expected corresponding PE for 2019-2021 is 26x / 22x / 19x respectively.Considering that the destocking effect will be basically digested in 2020, and performance growth will resume, we give the company a target PE conversion of 25x-27x in 2020 (comparable company’s PE average of 27x in 2020) and adjust the target price to 24.58-26.55 yuan, maintain “Buy” rating.  Risk Warning: Low inventory expectations; low online growth expectations.